Wednesday, March 04, 2020 9:58:18 PM
I hope so. Did you watch the video of CEO at the meeting at the White House? He noted several timelines - the NanoFlu data, COVID19 data (this week), and COVID19 non-human primate trial. He was a bit difficult to follow, but it seemed like a decent amount of information should be coming.
Recent NVAX News
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development • PR Newswire (US) • 03/30/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 09:00:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 10:13:36 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 03/09/2026 10:12:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:04:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:03:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:02:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:01:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 11:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:37:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:35:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:34:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 02:33:22 AM
- Novavax to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/26/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 01:02:10 PM
- Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights • PR Newswire (US) • 02/26/2026 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2026 12:33:51 PM
- Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 • PR Newswire (US) • 02/19/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 12:57:59 AM
- Novavax shares gain after Matrix-M adjuvant licensing deal with Pfizer • IH Market News • 01/20/2026 02:48:06 PM
- Novavax Announces Entering into a License Agreement with Pfizer • PR Newswire (US) • 01/20/2026 12:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 11:59:39 AM
